MS Drug Linked to Colorectal Cancer RiskMS Drug Linked to Colorectal Cancer Risk
Despite its cardiotoxicity -- and now possibly colorectal cancer risk -- mitoxantrone might still be an appropriate therapy in carefully selected patients, researchers say. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Cancer | Cancer & Oncology | Cardiology | Colorectal Cancer | Heart | Neurology | Neurosurgery